T38.3X2A Poisoning by insulin and oral hypoglycemic [antidiabetic] drugs, intentional self-harm, initial encounter

Name of the Condition

• Poisoning by insulin and oral hypoglycemic [antidiabetic] drugs, intentional self-harm, initial encounter

Summary

This condition involves intentional self-harm resulting from poisoning by insulin or oral hypoglycemic (antidiabetic) drugs during an initial encounter. It covers scenarios where these agents, used to manage blood glucose levels, are intentionally ingested or administered in harmful amounts, leading to adverse effects.

Causes

The causes include intentional overdose of insulin or oral hypoglycemics, often driven by self-harm intent. This may involve deliberate ingestion of excessive doses, misuse of prescribed or non-prescribed medications, or self-administration of insulin in harmful quantities.

Risk Factors

• Use of insulin or oral hypoglycemic therapies for diabetes management
• Access to antidiabetic medications
• History of self-harm or suicidal ideation
• Mental health conditions (e.g., depression, anxiety)
• Substance use disorders
• Social or environmental stressors

Symptoms

Symptoms reflect hypoglycemia or related metabolic effects, including confusion, dizziness, sweating, tachycardia, tremors, or loss of consciousness. Severe cases may involve seizures, coma, or cardiovascular instability. Onset and severity depend on the agent, dose, and individual factors.

Diagnosis

Diagnosis requires a thorough clinical evaluation, including patient history (e.g., intentional ingestion), physical examination, and laboratory tests (e.g., blood glucose, insulin levels, toxicology screens). Documentation of self-harm intent and initial encounter status is critical.

Treatment Options

Treatment focuses on stabilizing the patient, reversing hypoglycemia (e.g., glucose administration), and addressing complications. Interventions may include supportive care, antidotes (if applicable), and psychiatric evaluation. Hospitalization is often required for monitoring and management.

Prognosis and Follow-Up

Prognosis depends on the severity of poisoning, timeliness of treatment, and underlying health. Follow-up involves monitoring for recurrence, addressing mental health needs, and ensuring medication safety. Long-term care may include psychiatric support and medication management.

Complications

Complications can include severe hypoglycemia, seizures, coma, organ damage (e.g., renal or hepatic), or cardiovascular events. Delayed treatment may increase the risk of permanent harm or mortality.

Lifestyle & Prevention

Prevention strategies include secure medication storage, patient education on safe use, and addressing mental health concerns. Family or caregiver involvement may help reduce access to harmful substances.

When to Seek Professional Help

Seek immediate medical attention if self-harm with antidiabetic drugs is suspected or confirmed. Signs of poisoning (e.g., confusion, seizures, altered consciousness) require urgent evaluation.

Tips for Medical Coders

Document the intentional self-harm context and initial encounter status clearly. Ensure the code aligns with clinical documentation of intent and encounter type. Verify that the poisoning is attributed to insulin or oral hypoglycemics and not other substances.